Sartans in the Treatment of Hypertension
We recommend
Can Antihypertensives Reduce the Risk of Dementia? The Answer Suggests the Angiotensin Hypothesis and a Post-Hoc Analysis of an Observational Study
The use of antihypertensives that do not reduce angiotensin II levels, such as angiotensin receptor blockers (ARBs, i.e., sartans) and calcium channel blockers (CCBs), has been associated with a lower risk of dementia in studies. In the research cited below, the authors aimed to determine whether this effect persists longer than the follow-up period in previous studies.
Association Between Sartan Therapy and Lower Incidence of Epilepsy in Hypertensive Patients?
Arterial hypertension (AH) is one of the non-cerebral comorbidities of epilepsy, with the…
The main advantage of sartans is a very good safety profile. Now it is about increasing adherence in hypertensive patients
The rules for initiating hypertension treatment have been simplified. The trend is to achieve blood…
Articles on this topic
Combination of Candesartan with ACE Inhibitors in the Treatment of Hypertension and Heart Failure
Although the combination of ACE inhibitors and sartans is not recommended due to the higher…
Development of Albuminuria During Treatment with ACE Inhibitors and Sartans
Individual molecules from the class of renin-angiotensin system inhibitors display various…
Impact of Candesartan on Achieving Remission in Patients with Active IgA Nephropathy
IgA nephropathy is the most common glomerulonephritis worldwide and in the Czech Republic. The…
Impact of Lifestyle on the Benefit of Pharmacotherapy for Hypertension and Dyslipidemia
Antihypertensive and hypolipidemic therapy reduces the risk of cardiovascular (CV) diseases.…
Could candesartan counteract adverse intestinal changes induced by hypertension?
An experimental study published last year was the first to show that administration of…
Effects of Telmisartan on Vascular Endothelial Functions, Inflammation Parameters, and Insulin Resistance in Patients with CHD and DM
Patients with coronary heart disease (CHD) and diabetes mellitus (DM) often have dysfunctional…
Metabolic Effect of Telmisartan and Candesartan in Kidney Transplant Patients
Increasing cardiovascular risk from complex causes warrants a comprehensive intervention. A…
Subscribe
Most read on this topic
Journal on this topic
Related topic
Interesting links
Most read on this topic
- About Sartans: An Overview with Consideration of Their Position in the Current Coronavirus Situation
- Adequate Compensation of a Hypertensive Patient According to Current ESC Guidelines – Case Study
- Candesartan Could Ameliorate the Cytokine Storm in COVID-19 Infection
- Fixed Combination of Candesartan/Amlodipine in the Treatment of Arterial Hypertension
- Telmisartan – antihypertensive with cardioprotective effects
- Impact of ACEi and ARBs on Lung Function in Patients with Hypertension
Journal on this topic
Related topic
Interesting links